logo

For the Inventor, By the Inventor

Nanuet, NY, United States of America

Herbert J Brabander

USPTO Granted Patents = 16

Average Co-Inventor Count = 2.8

ph-index = 4

Forward Citations = 75(Granted Patents)


Location History:

  • Nauet, NY (US) (1990)
  • Nanuet, NY (US) (1979 - 1997)

Company Filing History:

goldMedal15 out of 3,580 
 
American Cyanamid Company
 patents
silverMedal1 out of 1,567 
 
American Home Products Corporation
 patents

Years Active: 1979-1997

Loading Chart...
16 patents (USPTO):Explore Patents
1. 5637731 - Substituted oxotremorine derivatives (1997-06-10),
2. 5550257 - Substituted oxotremorine derivatives (1996-08-27),
3. 5451685 - Substituted oxotremorine derivatives (1995-09-19),
4. 5356885 - Substituted oxotremorine derivatives and pharmaceutical use thereof (1994-10-18),
5. 5346910 - Maleimide derivatives of oxotremorine (1994-09-13),
6. 5219857 - Method of treating cognitive and related neural behavioral problems (1993-06-15),
7. 5126340 - 4-[(substituted)alkylcarbonyl]-4,5-dihydro and (1992-06-30),
8. 5089518 - 3- or 4-substituted oxotremorine derivatives and a method of treating (1992-02-18),
9. 5025099 - (3-amino-1-propynyl)methylthiothiophene derivatives (1991-06-18),
10. 4990520 - 2-,4- or 5-substituted thiazole derivatives (1991-02-05),
11. 4963553 - 4-[(substituted) alkylcarbonyl]-4,5-dihydro- and (1990-10-16),
12. 4963552 - 1-substitute-1,2-dihydro-4-((substituted)phenyl)imidazo-[1,5-a] (1990-10-16),
13. 4952600 - 3- or 4-substituted oxotremorine derivatives and a method of treating (1990-08-28),
14. 4937235 - 3- or 4-substituted oxotremorine derivatives (1990-06-26),
15. 4435419 - Method of treating depression using azabicyclohexanes (1984-03-06),

Title: The Innovative Journey of Herbert J. Brabander

Introduction

Herbert J. Brabander, an accomplished inventor based in Nanuet, NY, has made significant contributions in the field of medicinal chemistry. With a remarkable portfolio of 16 patents, Brabander's work primarily focuses on novel compounds with therapeutic potential for diseases affecting the central nervous system.

Latest Patents

Among his latest innovations are the substituted oxotremorine derivatives. This invention describes novel derivatives of formula I that contain nitrogen, oxygen, or sulfur groups, as well as their prodrug forms. These compounds exhibit cholinergic activity, which is crucial for treating various central nervous system disorders in mammals. His work also encompasses pharmaceutical preparations that utilize these compounds and the methods involved in producing them, showcasing his deep understanding of medicinal chemistry.

Career Highlights

Throughout his career, Brabander has worked with renowned companies such as American Cyanamid Company and American Home Products Corporation. His expertise and innovative spirit have not only contributed to his personal success but have also advanced the field of pharmaceuticals, making a lasting impact on the industry.

Collaborations

Brabander has collaborated with notable coworkers like Eugene J. Trybulski and Richard H. Kramss, further enhancing his role in innovative research and development. These collaborations reflect the collective effort in advancing scientific knowledge and creating valuable medicinal products.

Conclusion

Herbert J. Brabander's dedication to innovation has led to pivotal breakthroughs in pharmaceutical science. His patents, particularly in the realm of cholinergic compounds, underscore his commitment to improving health outcomes for patients. With a career marked by significant achievements and collaborations, Brabander exemplifies the spirit of innovation in today's scientific landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…